KENNETH I CHENAULT
CIK 1180524 · Chairman & CEO · last filed 2026-07-01
KENNETH I CHENAULT is a Chairman & CEO who has filed 155 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ABNB, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$557.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $410.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$410.93M
6
155
-$557.23M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABNB | Director | 40,879 | $153.01 | $6.25M | -$1.25M | 8 | 2026-07-01 |
| Livongo Health, Inc. (LVGO) Delisted | 10%+ Owner | 971,064 | — | — | -$111.05M | 2 | 2020-06-26 |
| FB | Director | 3,717 | $44.18 | $164.2K | $0 | 6 | 2020-05-19 |
| IBM | Director | 8,648 | $226.44 | $1.96M | -$3.90M | 55 | 2019-01-02 |
| PG | Director | 41,010 | $146.10 | $5.99M | $65.7K | 39 | 2018-12-12 |
| AXP | Chairman & CEO | 1,196,258 | $331.50 | $396.56M | -$441.10M | 44 | 2018-01-30 |
Recent Filings
155 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | ABNB | Mixed | — | -$751.9K | EDGAR |
| 2026-06-29 | ABNB | Notice (144) | −8,346 | -$1.25M | EDGAR |
| 2026-05-27 | ABNB | Grant (A) | +3,135 | $0 | EDGAR |
| 2025-05-28 | ABNB | Grant (A) | +3,274 | $0 | EDGAR |
| 2024-05-29 | ABNB | Grant (A) | +2,872 | $0 | EDGAR |
| 2023-05-30 | ABNB | Grant (A) | +3,974 | $0 | EDGAR |
| 2022-05-27 | ABNB | Grant (A) | +3,600 | $0 | EDGAR |
| 2021-05-27 | ABNB | Grant (A) | +2,966 | $0 | EDGAR |
| 2020-12-11 | ABNB | Grant (A) | +21,058 | $0 | EDGAR |
| 2020-06-26 | Livongo Health, Inc. (LVGO) Delisted | Other (J) | +27,349 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.